Journey Medical DERM
NASDAQ DERM
$4.52 +0.05 (+1.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Journey Medical (DERM) Depreciation & Amortization (CF) (2020)

Updated

Journey Medical's Depreciation & Amortization (CF) came in at $1,000 for Q4 2020, unchanged from the prior quarter.

Analysis

Journey Medical (DERM) Depreciation & Amortization (CF) (2020) Analysis & Trends

For FY2020, Journey Medical's Depreciation & Amortization (CF) was $5,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.12 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 192.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 132.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.58 Bn
10 Journey Medical 123.72 Mn 21.81 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 1,000.00
Sep 30, 2020 1,000.00
API Access

Journey Medical Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DERM&period=max&api_key=YOUR_API_KEY